# FARXIGA

NDC: 50090-3481
Generic name: DAPAGLIFLOZIN
Labeler / Manufacturer: A-S Medication Solutions
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20080114

FDA application: NDA202293

## Active ingredients

- DAPAGLIFLOZIN PROPANEDIOL: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50090-3481"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50090-3481
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=01f90c94-71cb-4a1f-81ff-8004b850529b